Institutions Holding Call Options on C4 Therapeutics, Inc. (CCCC)
This table provides information about the call option holders of C4 Therapeutics, Inc. (CCCC). We have compiled data on the institutions that hold call options on the stock, with a total of 669,500 call options outstanding, which have been reported (via 13F filing form) to have a value of $2.57 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
187,600
calls
|
$688,492
0.0% of portfolio
|
Q3 2024
Reduced 28.1%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
150,000
calls
|
$550,500
0.02% of portfolio
|
Q3 2024
New holding
|
|
|
Silverarc Capital Management, LLC
|
Nov 14, 2024 Q3 2024 |
150,000
calls
|
$550,500
0.21% of portfolio
|
Q3 2024
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
85,100
calls
|
$312,317
0.0% of portfolio
|
N/A
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
32,800
calls
|
$120,376
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Citigroup Inc
|
Nov 12, 2024 Q3 2024 |
25,000
calls
|
$91,750
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Wolverine Trading, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
18,500
calls
|
$67,895
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Valence8 Us LP
Cambridge, MA |
Nov 12, 2024 Q3 2024 |
10,500
calls
|
$38,535
0.02% of portfolio
|
Q3 2024
New holding
|
|
|
Nomura Holdings Inc
Tokyo, M0 |
Nov 14, 2024 Q3 2024 |
10,000
calls
|
$36,700
0.0% of portfolio
|
Q3 2024
New holding
|